LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024 LPCN stock results show that Lipocine beat analyst estimates for earnings per share the first quarter of 2024.
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023 LPCN stock results show that Lipocine beat analyst estimates for earnings per share the fourth quarter of 2023.
LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024 LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
7 Penny Biotech Stocks to Triple Your Investment Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Femasys Inc. (
NASDAQ: FEMY ) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Why Lipocine Stock Is Moving Higher Today? Lipocine Inc (
NASDAQ: LPCN ) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the
Why Is National Vision (EYE) Stock Down 12% Today? National Vision (EYE) stock is dropping on Thursday as a deal it has with Walmart (WMT) is going to come to an end in 2024.
Why Is Yellow (YELL) Stock Down 27% Today? Yellow (YELL) stock is falling on Thursday as reports claim the transportation company is preparing to file for bankruptcy.
